The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Androgen Treatment of Abdominally Obese Men
Open accessAbstract
Middle‐aged men with abdominal obesity were treated in a double‐blind study with moderate doses of transdermal preparations of testosterone (T), dihydrotestosterone (DHT), or placebo. This resulted in moderately elevated T concentrations and marked decreases in follicle stimulating and luteinizing hormones in the group treated with T, while the DHT group showed elevated DHT, markedly lower T values, and less diminution of gonadotropin concentrations. In the group treated with T visceral fat mass decreased (measured by computerized tomography) without significant changes in other depot fat regions. Lean body mass did not change. In the group treated with T, glucose disposal rate, measured with the euglycemic hyperinsulinemic clamp method, was markedly augmented. Plasma triglycerides, cholesterol, and fasting blood glucose concentrations as well as diastolic blood pressure decreased. There were no such changes in the DHT or placebo treatment groups. The men treated with T reported increased well‐being and energy. In none of the groups did prostate volume, specific prostate antigen concentration, genitourinary history, or urinary flow measurement change. It is suggested that supplementation of abdominal obese men with moderate doses of T might have several beneficial effects. (OBESITY RESEARCH 1993;1:245–251)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The decrease in serum triglycerides follows a similar pattern: after 4 weeks (38), after 3 months (35), and with further decrease over 9 months (41) or 12 months (43).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [41]
In the citing paper
“In some studies a decline in diastolic blood pressure has been observed, after 3–9 months (22, 35, 41, 44) and in some studies in systolic blood pressure also (35, 44).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Kvist, H., Chowdhury, B., Grangård, U., Tylén, U., & Sjöström, L. (1988) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/48.6.1351 · Cited by 794
Self-citationSeidell, J. C., Björntorp, P., Sjöström, L., Kvist, H., & Sannerstedt, R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90297-p · Cited by 567
Self-citationThe effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
Mårin, P., Holmäng, S., Jönsson, L., Sjöström, L., Kvist, H., Holm, G., Lindstedt, G., & Björntorp, P. A. (1992) · PubMed · Cited by 553
Self-citationVague, P., Juhan-Vague, I., Aillaud, M. F., Badier, C., Viard, R., Alessi, M., & Collen, D. (1986) · Metabolism · doi:10.1016/0026-0495(86)90209-x · Cited by 443
Percutaneous Absorption of Steroids*
Scheuplein, R. J., Blank, I. H., Brauner, G., & Macfarlane, D. J. (1969) · Journal of Investigative Dermatology · doi:10.1038/jid.1969.9 · Cited by 392
Testosterone: A Major Determinant of Extragenital Sexual Dimorphism
Bardin, C. W., & Catterall, J. F. (1981) · Science · doi:10.1126/science.7010603 · Cited by 381
Estimation of Total Body Fat from Potassium-40 Content
Forbes, G. B., Gallup, J., & Hursh, J. B. (1961) · Science · doi:10.1126/science.133.3446.101 · Cited by 341
Abdominal obesity and the development of noninsulin‐dependent diabetes mellitus
Björntorp, P. A. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040607 · Cited by 292
Self-citationEffect of testosterone on abdominal adipose tissue in men.
Rebuffé-Scrive, M., Mårin, P., & Björntorp, P. A. (1991) · PubMed · Cited by 223
Self-citation
Research works printed but not linked: 2
- Arvidsson B., 1972, Clinical applications of a high‐sensitivity whole‐body counter, Digest of the Third International Conference on Medical Engineering. Gothenburg, 41, 2
- WHO, 1988, Measuring obesity; classification and description of anthropometric data. Report on a WHO consultation on the epidemiology of obesity. EURMFA target 16. Regional office in Europe, 1
Cited by
Sorted by citations
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Vigen, R. (2013) · JAMA · doi:10.1001/jama.2013.280386 · Cited by 1,003
Gender differences in insulin resistance, body composition, and energy balance
Geer, E. B., & Shen, W. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.02.002 · Cited by 913
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 596
Metadata
- Authors
- Mårin, P., Holmtäng, S., Gustafsson, C., Jönsson, ‡., Kvist, ‡., Elander, A., Eldh, J., Sjöström, L., Holm, G., & Björntorp, P.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Corresponding author
- Mårin, Per
- Venue
- Obesity Research
- Publisher
- Wiley
- Published
- 1993-07
- Volume
- 1
- Issue
- 4
- Pages
- 245-251
- ISSN
- 1071-7323 (ISSN-L)
- 1550-8528
- OpenAlex
- W2009810419
- Cited by
- 345
- References
- 19
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 8 · 2019: 9 · 2018: 10 · 2017: 14 · 2016: 8 · 2015: 17 · 2014: 18 · 2013: 18 · 2012: 19
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Obesity Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- androgen therapy, abdominal obesity, testosterone, dihydrotestosterone, visceral fat, glucose disposal, insulin sensitivity, gonadotropins, blood pressure, lipid profile, middle-aged men, prostate volume
- MeSH terms
- Adult, Aged, Androgens, Blood Glucose, Blood Pressure, Body Composition, Body Weight, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Type 2, Double-Blind Method, Glucose, Gonadotropins, Humans, Male, Middle Aged, Obesity, Placebos, Risk Factors, Sex Hormone-Binding Globulin, Dihydrotestosterone, Testosterone, Time Factors, Tomography, X-Ray Computed, Triglycerides, Prostate-Specific Antigen, Abdominal Fat, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
